An Unintended Consequence: Atal Amiodarone Pulmonary Toxicity in an Older Woman

Journal of the American Medical Directors Association

Volumn 7, Issue 8, 2006, Pages 510-513

  Wang, Tisha ^a   Charette, Susan ^a   Smith, M Iain ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ATORVASTATIN; AZITHROMYCIN; CELECOXIB; CORTICOSTEROID DERIVATIVE; FOLIC ACID; LEVOFLOXACIN; LOSARTAN; MEMANTINE; MORPHINE; WARFARIN; ANTIARRHYTHMIC AGENT;

AGED; ANAMNESIS; APPETITE DISORDER; ARTICLE; AUTOPSY; BRONCHIECTASIS; CASE REPORT; CAUCASIAN; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COUGHING; DISEASE DURATION; DYSPNEA; ELECTRON MICROSCOPY; FATALITY; FATIGUE; FEMALE; FIBROSING ALVEOLITIS; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; KIDNEY FAILURE; LABORATORY TEST; LEUKOCYTOSIS; LIVER DYSFUNCTION; LOBAR PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LUNG TOXICITY; MITRAL VALVE REPLACEMENT; PHYSICAL EXAMINATION; RISK ASSESSMENT; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT WITHDRAWAL; LUNG DISEASE; MORTALITY; RISK FACTOR; UNITED STATES;

AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; FEMALE; HUMANS; LOS ANGELES; LUNG DISEASES; RISK FACTORS;

EID: 33749255186     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2006.07.001     Document Type: Article

References (13)

1. Olshansky B., Sami M., Rubin A., et al., NHLBI AFFIRM Investigators. Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study. Am J Cardiol 95 3 (2005) 404-405
2. Singh S.N., Fisher S.G., Deedwania P.C., et al. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No 320). J Am Coll Cardiol 30 2 (1997) 514-517
3. Camus P., Martin II W.J., and Rosenow III E.C. Amiodarone pulmonary toxicity. Clin Chest Med 25 1 (2004) 65-75
4. Coudert B., Bailly F., Lombard J.N., et al. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature. Chest 102 (1992) 1005-1012
5. Ott M.C., Khoor A., Leventhal J.P., et al. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 123 2 (2003) 646-651
6. Kharabsheh S., Abendroth C.S., and Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol 89 7 (2002) 896-898
7. Handschin A.E., Lardinois D., Schneiter D., et al. Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration 70 3 (2003) 310-312
8. Goldschlager N., Epstein A.E., Naccarelli G., et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med 160 12 (2000) 1741-1748
9. Stelfox H.T., Ahmed S.B., Fiskio J., and Bates D.W. Monitoring amiodarone's toxicities: Recommendations, evidence, and clinical practice. Clin Pharmacol Ther 75 1 (2004) 110-122
10. Van Mieghem W., Coolen L., Malysse I., et al. Amiodarone and the development of ARDS after lung surgery. Chest 105 6 (1994) 1642-1645
11. Saxonhouse S.J., and Curtis A.B. Risks and benefits of rate control versus maintenance of sinus rhythm. Am J Cardiol 91 6A (2003) 27D-32D
12. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 23 (2002) 1825-1833
13. Sunderji R., Kanji Z., and Gin K. Pulmonary effects of low dose amiodarone: A review of the risks and recommendations for surveillance. Can J Cardiol 6 11 (2000) 1435-1440